|
PPWD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.994600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.225000E-01 |
| Normal-vs-Stage2 |
5.853000E-01 |
| Normal-vs-Stage3 |
5.296000E-01 |
| Normal-vs-Stage4 |
7.079600E-01 |
| Stage1-vs-Stage2 |
6.227200E-01 |
| Stage1-vs-Stage3 |
4.407800E-01 |
| Stage1-vs-Stage4 |
7.266200E-01 |
| Stage2-vs-Stage3 |
3.598400E-01 |
| Stage2-vs-Stage4 |
5.593800E-01 |
| Stage3-vs-Stage4 |
8.824000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.976800E-01 |
| Normal-vs-AfricanAmerican |
5.715600E-01 |
| Normal-vs-Asian |
1.772980E-01 |
| Caucasian-vs-AfricanAmerican |
7.442200E-01 |
| Caucasian-vs-Asian |
4.599600E-02 |
| AfricanAmerican-vs-Asian |
9.403500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.816600E-01 |
| Normal-vs-Female |
2.202000E-01 |
| Male-vs-Female |
2.507800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.603600E-01 |
| Normal-vs-Extreme_Weight |
9.773200E-01 |
| Normal-vs-Obese |
4.759200E-01 |
| Normal-vs-Extreme_Obese |
2.340400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.551600E-01 |
| Normal_Weight-vs-Obese |
3.289600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.747200E-01 |
| Extreme_Weight-vs-Obese |
5.010600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.100400E-01 |
| Obese-vs-Extreme_Obese |
2.728400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.922590E-01 |
| Normal-vs-Age(41-60Yrs) |
8.844300E-02 |
| Normal-vs-Age(61-80Yrs) |
7.288800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.269580E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.500600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.118050E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.901600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.002400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.442000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.430200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.959220E-01 |
| Normal-VS-Type2 PRCC |
2.888800E-01 |
| Normal-VS-KIRP CIMP |
2.967500E-02 |
| Normal-VS-Unclassified PRCC |
3.122600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.373600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.606400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.620400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.348000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.320500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.811890E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.150200E-01 |
| Normal-vs-N1 |
3.964800E-01 |
| Normal-vs-N2 |
7.971800E-01 |
| N0-vs-N1 |
1.252800E-01 |
| N0-vs-N2 |
9.679000E-01 |
| N1-vs-N2 |
5.085000E-01 |
|
|
